CIK 0001878313
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
MAIA Biotechnology, Inc.
Sign in to watch- Ticker
- MAIA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 312-416-8592
- Business address
- 444 WEST LAKE STREET, SUITE 1700, CHICAGO, IL, 60606
- Open-market buys, last 90 days
- $352,317
- in 5 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$352,317. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 36 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-17 | Guerrero Ramiro Director | Purchase | +50 | $4.25 | $213 | 297,524.04 |
| 2023-02-17 | Luput Cristian Director | Purchase | +76 | $4.24 | $322 | 278,730 |
| 2023-02-16 | Smith Stan Director | Purchase | +62 | $4.25 | $264 | 514,171 |
| 2023-02-16 | Guerrero Ramiro Director | Purchase | +10 | $4.25 | $43 | 297,474.04 |
| 2023-02-16 | Luput Cristian Director | Purchase | +58 | $4.25 | $247 | 278,654 |
| 2023-02-16 | Vitoc Vlad Chief Executive Officer | Purchase | +10 | $4.25 | $43 | 793,484 |
| 2023-02-15 | Vitoc Vlad Chief Executive Officer | Purchase | +10 | $4.25 | $43 | 793,474 |
| 2023-02-15 | Smith Stan Director | Purchase | +10 | $4.25 | $43 | 514,109 |
| 2023-02-14 | Smith Stan Director | Purchase | +198 | $4.25 | $842 | 514,099 |
| 2022-09-19 | Smith Stan Director | Purchase | +2,700 | $3.69 | $10K | 1,424,178 |
Page 14 of 14 · 270 trades